Showing results (801-810 of 1,147) with videos related to
Sort By:
Pageof 115
Journal of Hepatocellular Carcinoma|June 22, 2026
Subgroup-Specific Nomogram for Refined Risk Stratification in Hepatocellular Carcinoma Patients with Low LDL-CBojun Liu, Zhixia Gu, Ling Li, et al.Journal of Hepatocellular Carcinoma|June 29, 2026
Multimodal Modeling Distinguishes Treatment Response from Overall Survival in Hepatocellular Carcinoma Receiving Combined Interventional and Targeted ImmunotherapyDonghai Lu, Pengfei Sun, Han Li, et al.Journal of Hepatocellular Carcinoma|May 13, 2021
Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular CarcinomaYanfen Fan, Yixing Yu, Ximing Wang, et al.Journal of Hepatocellular Carcinoma|June 24, 2026
Intratumoral Fibrosis is a Potential Biomarker in Patients with Hepatocellular Carcinoma Undergoing Liver ResectionQi-Yuan Deng, Tian-Cheng Wang, Kun YeJournal of Hepatocellular Carcinoma|June 24, 2026
TACE Combined with Ralox-HAIC (Oxaliplatin Puls Raltitrexed) and System Therapy in Patients with Unresectable Hepatocellular CarcinomaRuiqing Liu, Guangshao Cao, Lupeng Li, et al.Journal of Hepatocellular Carcinoma|June 22, 2026
Aberrant Cholesterol Metabolism Caused by Decreased Lecithin: Cholesterol Acyltransferase Promoted HepatocarcinogenesisHongliang Gao, Xing Peng, Yali Wen, et al.Journal of Hepatocellular Carcinoma|June 23, 2026
Prognostic Value of the SEA Score in Double-Negative DCP/AFP Unresectable HCC with Triple TherapyHesheng Lin, Fulin Ran, Jiayi Wu, et al.Journal of Hepatocellular Carcinoma|June 25, 2026
Current Status and Emerging Trends in Global Research on Liposome Therapy for Hepatocellular Carcinoma: A Bibliometric AnalysisXiaotao Hong, Yibo Wu, Xiaocong Wu, et al.Journal of Hepatocellular Carcinoma|June 2, 2026
Efficacy of Locoregional HAIC and Systemic Treatment for Treatment- Naive Unresectable Hepatocellulcar CarcinomaMaopei Chen, Li Zhang, Chengfeng Liu, et al.Journal of Hepatocellular Carcinoma|May 28, 2026
Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular CarcinomaZhipeng Feng, Xiaolong Wang, Junming Xu, et al.Pageof 115